Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey

Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are common autoimmune diseases (AD) that affect joints and have multi-organ involvement that results in disability, morbidity, and increased mortality. Both conditions are known to cause a wide range of ocular manifestations. Antimalar...

Full description

Saved in:
Bibliographic Details
Published inHealthcare (Basel) Vol. 10; no. 3; p. 565
Main Authors Aldarwesh, Amal, Almustanyir, Ali, Alhayan, Duja, Alharthi, Mazoon, Alblowi, Mohammed
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 17.03.2022
MDPI
Subjects
autoimmune disease
Autoimmune diseases
Chronic illnesses
Confidence
Cross-sectional studies
Disease
Health education
Health literacy
Higher education
Likert scale
Patients
Quality of life
Questionnaires
Rheumatoid arthritis
Self-efficacy
systemic lupus erythematosus
autoimmune disease
systemic lupus erythematosus
self-efficacy
Online AccessGet full text

Cover

More Information
Summary:Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are common autoimmune diseases (AD) that affect joints and have multi-organ involvement that results in disability, morbidity, and increased mortality. Both conditions are known to cause a wide range of ocular manifestations. Antimalarial drugs, mainly hydroxychloroquine (HCQ), are among the treatment options for AD that is uniquely characterized by retinopathy as a main side effect. This study examines self-efficacy levels in autoimmune disease patients who were or are currently treated with HCQ and related factors such as patient education, communication with the physician, self-education, and ability to cope with the disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2227-9032
2227-9032
DOI:10.3390/healthcare10030565